Clinical Trials Browser

Completed × NETWORK × Trabectedin × Clear all

NCT02234050 2025-07-10

Trabectedin for Recurrent Grade II/III Meningioma

Phase 2 Completed

90 enrolled 18 charts

Recurrent High Grade Meningioma

NCT03023124 2024-12-09

STRADA

Phase 2 Completed

Solitary Fibrous Tumors

NCT02247544 2021-11-01

TRAVELL

Phase 2 Completed

Leiomyosarcoma, Liposarcoma, Ichthyosis, X-Linked

NCT02398058 2021-04-14

TOMAS

Phase 1 Completed

Bone Neoplasms, Sarcoma

NCT02793050 2019-05-10

TrObs

Sarcoma

NCT00070109 2018-09-14

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Phase 2 Completed

50 enrolled 18 charts

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

NCT02066675 2018-04-11

TR1US

Phase 2 Completed

Neoplasm Metastasis, Soft Tissue Neoplasms

NCT00379145 2017-12-12

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Phase 2 Completed

20 enrolled 7 charts

Sarcoma

NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00003939 2012-09-24

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

CNSGastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous